Lack of GNAQ and GNA11 germ-line mutations in familial melanoma pedigrees with uveal melanoma or blue nevi
Approximately 10% of melanoma cases are familial, but only 25-40% of familial melanoma cases can be attributed to germ-line mutations in the CDKN2A - the most significant high-risk melanoma susceptibility locus identified to date. The pathogenic mutation(s) in most of the remaining familial melanoma...
Main Authors: | Jason Ezra Hawkes, Jennifer eCampbell, Daniel eGarvin, Lisa eCannon Albright, Pamela eCassidy, Sancy A Leachman |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00160/full |
Similar Items
-
Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patients
by: Sandra García-Mulero, et al.
Published: (2023-12-01) -
<i>GNAQ</i> and <i>GNA11</i> Genes: A Comprehensive Review on Oncogenesis, Prognosis and Therapeutic Opportunities in Uveal Melanoma
by: Paula Silva-Rodríguez, et al.
Published: (2022-06-01) -
Uveal melanoma: epidemiology, etiology, and treatment of primary disease
by: Krantz BA, et al.
Published: (2017-01-01) -
BRAF, NRAS, KIT, TERT, GNAQ/GNA11 Mutation Profile and Histomorphological Analysis of Anorectal Melanomas: A Clinicopathologic Study
by: Orhun Cig TASKIN, et al.
Published: (2023-01-01) -
A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanoma
by: Sebastian Bauer, et al.
Published: (2023-06-01)